Providers must submit detailed narratives explaining why GLP-1 therapy suits individual patient circumstances rather than relying on standard diagnosis codes alone
Do not use cloudy medication
The interaction of AGEs with specific receptors, particularly the receptor for advanced glycation end-products (RAGE), triggers multiple intracellular signaling pathways, including NF-B, ERK1/2, p38, and MAPK, which in turn promote inflammatory responses and cellular stress (Yoshikawa et al., 2022
If lifestyle optimization plateaus or health indicators worsen, professional-guided pharmaceutical or compounded GLP-1 options become clinically relevant
We continue to follow up on all concerns raised and conduct inspections to ensure that pharmacies are meeting our standards